Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
In today's edition of Market Checkup, health-care analysts David Williamson and Max Macaluso take a close look at Onyx Pharmaceuticals, which may or may not be acquired in the coming weeks, and Eli Lilly, which recently announced positive clinical trial results for an experimental cancer drug.
It's no secret that biotech stocks have been soaring recently, but the best investment strategy is to pick great companies and stick with them for the long term. The Motley Fool's free report, "3 Stocks That Will Help You Retire Rich," not only shares stocks that could help you build long-term wealth, but also winning strategies that every investor should know. Click here to grab your free copy today.